2 Patents
- US126167502026Combination Therapy Utilizing DNA Alkylating Agents and ATR Inhibitors
Merck Patent GmbH
0 cites - US122275772025Combination of a PD-1 Antagonist, an ATR Inhibitor and a Platinating Agent for the Treatment of Cancer
Merck Patent GmbH
0 cites